The frequency of tumour-infiltrating HLA-DR-CD33+CD11b+CD15+ MDSC subset was markedly higher than that of the monocytic Lin-HLA-DR-CD14+ subset but this did not reach a statistical significance (11.11% versus 3.85%, P = 0.073). The gene discussed is CD33; the disease is neoplasm.